Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Abstract Psilocybin is the most researched classic psychedelic for Treatment-Resistant Depression (TRD). While optimizing set and setting are considered essential for efficacy and safety, patient perspectives on these aspects have rarely been investigated. To address this knowledge gap, the current...

Full description

Bibliographic Details
Main Authors: Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, Tilman Karsten, Jeanine Kamphuis, Eric Vermetten, Wim van den Brink, Robert Schoevers
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-53188-9

Similar Items

Similar Items